Carmen is our Accounts Administrator, supporting the Pearce IP Team with the financial aspects of the business.
Carmen has more than 30 years’ as a chartered accountant including in business management roles.
In her early professional life Carmen worked as a chartered accountant with Ernst & Young, primarily supporting banking and financial investment clients in the EY audit division. This was followed with sixteen years at JPMorgan in accounting, business analysis and project management roles in the superannuation custodial business, with some of Australia’s largest superannuation funds and fund managers as her clients.
Most recently, Carmen was the Business Manager at an independent secondary college leading all non-academic aspects of the college.
Carmen is passionate about providing excellent financial services support to Pearce IP and its clients.
Pearce IP Awards
Chambers and Partners
Intellectual Property (2024)
Legal 500 Asia Pacific
Market Leading Intellectual Property Firm (2024)
Market Leading Intellectual Property Firm (2023)
IAM Patent 1000
Bronze for litigation (2023, 2022, 2021)
Bronze for prosecution (2024, 2023, 2022, 2021)
Australian Law Awards (Lawyers Weekly)
Finalist – Women in Law Awards – Boutique Diversity Firm of the Year (2022)
Finalist – Intellectual Property Team of the Year (2022)
Winner – Intellectual Property Team of the Year (2021)
Managing IP Stars
Patent Prosecution (2024, 2023, 2022)
The Only Leading Female Owned Life Sciences focussed IP Firm (2023)
Pearce IP ranked firm (2021)
Women in Business Law Awards - APAC
Shortlisted – Australian Firm of the Year (2022)
Lexology Legal Influencer
Australasia – Healthcare and Life Sciences (Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020)
Cross-border – Healthcare and Life Sciences (Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023)
Australasian Lawyer
Top Boutique Firm (2024)
5-Star Intellectual Property Law Firm (2021)
Doyles Intellectual Property
Doyles Leading Intellectual Property (2021, 2020)
Doyles Recommended Intellectual Property (2021)
OUR VISION
By 2027, be the premier life sciences IP practice in
Australia and New Zealand.